In March 2010, a class proceeding was commenced against Bayer Inc. on behalf of all persons in Ontario who used Yasmin® and YAZ® between the times these drugs were first made available in Canada (2004 and 2008 respectively) and November 30, 2011.
The claim alleges that both Yasmin® and YAZ® are associated with an increased risk of suffering various types of blood clots and gallbladder disease, compared to other available oral contraceptives. The claim further alleges that the increased risk was known to Bayer Inc. and they failed to timely or adequately communicate the risk information to consumers and the medical community.
Attached is a copy of the Second Fresh As Amended Statement of Claim.
Attached is a copy of the Amended Statement of Claim.
On April 15, 2013, the Honourable Justice Crane of the Ontario Superior Court of Justice certified this case as a class proceeding. View a copy of the certification decision here.
View a copy of the notice of certification here.
View a copy of the press release with respect to certification here.
The Ontario action applies to all residents of Ontario who were prescribed Yasmin and/or Yaz prior to November 30, 2011.
The Saskatchewan action applies to all residents of Canada, excluding Ontario and Quebec, who were prescribed Yasmin and/or Yaz prior to September 17, 2015.
The Quebec action applies to all residents of Quebec who were prescribed Yasmin and/or Yaz prior to November 30, 2011.
On August 5, 2015, Bayer filed its Statement of Defence. Attached is a copy of the Statement of Defence.
On September 17, 2015, the Saskatchewan Court released its certification decision indicating that it will certify a Yasmin/Yaz class action for Canadians outside of Ontario and Quebec subject to having the litigation plan updated. View a copy of the Sept 17, 2015 Saskatchewan certification decision here.
On October 4, 2016, the Saskatchewan Court released the second part of its certification decision indicating the Saskatchewan national action is now certified.; View a copy of the Oct 4, 2016 Saskatchewan certification decision here.
On February 15, 2019, the Quebec Court authorized a class action against Bayer Inc.. On May 14, 2019, the Quebec Court approved the notices to members (French and English), aiming to inform them from the above and of their right to opt-out. The Opt-Out Deadline is September 4, 2019 for the Quebec Action. View a copy of the French & English Notice(s) here.
McKenzie Lake Lawyers LLP is representing women across Canada who suffered a pulmonary embolism, deep vein thrombosis, and/or stroke while using Yasmin or Yaz, and/or gallbladder disease/removal following use of Yasmin and/or Yaz.
For updates on the Yasmin/Yaz class action and/or to share your experience, visit the Facebook page Take Your Body Back
Contact Us
For any inquiries with respect to this class action, please contact us directly by email or by phone at 1-844-672-5666. If corresponding by email, be sure to include your name, your telephone number and a brief message.
